Univfy

About:

Univfy AI Platform makes fertility costs and success more predictable for women and couples navigating their family-building options.

Website: https://www.univfy.com

Twitter/X: Univfy

Top Investors: Rethink Impact, Atlantic Street Capital

Description:

The Univfy AI Platform helps women and couples navigate their family-building options with cost-savings, greater success, and a simplified experience. Univfy combines AI/machine learning, clinical expertise, and empathy to maximize each patient’s chances of success with assisted reproductive technology such as in vitro fertilization (IVF) while increasing growth and efficiency for physicians. Univfy is the only highly-scalable AI platform to provide scientifically-validated, personalized reports that counsel patients from diverse demographics about their probability of having a baby with IVF. Through technology developed by Stanford University researchers, Univfy uses a rigorous scientific process to develop and validate prediction models and to provide essential information to support better budgeting, planning, and physician-patient shared decision-making. Its methods have been published in the top, peer-reviewed research publications, setting a gold standard for IVF success model performance metrics. Univfy has a global IP portfolio, comprising patents issued in the US and other countries.

Total Funding Amount:

$12.7M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Los Altos, California, United States

Founded Date:

2009-11-06

Contact Email:

info(AT)univfy.com

Founders:

Mylene Yao, Wing Wong

Number of Employees:

11-50

Last Funding Date:

2021-12-20

IPO Status:

Private

© 2024 MyAiNote.com